You just read:

MAP Pharmaceuticals to Present Data From LEVADEX® Pharmacokinetics and Pharmacodynamics Safety Studies at the 63rd Annual Meeting of the American Academy of Neurology

News provided by

MAP Pharmaceuticals, Inc.

Apr 12, 2011, 07:00 ET